Vyne Therapeutics Inc banner

Vyne Therapeutics Inc
NASDAQ:VYNE

Watchlist Manager
Vyne Therapeutics Inc Logo
Vyne Therapeutics Inc
NASDAQ:VYNE
Watchlist
Price: 0.6124 USD 0.53%
Market Cap: $20.4m

Cash Flow Statement

Cash Flow Statement
Vyne Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
(20)
(20)
(25)
(29)
(36)
(38)
(43)
(51)
(54)
(65)
(75)
(74)
(99)
(247)
(249)
(256)
(236)
(88)
(85)
(73)
(48)
(37)
(25)
(23)
(34)
(35)
(32)
(28)
(29)
(28)
(34)
(40)
(42)
(39)
(34)
(26)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
1
1
1
2
2
3
4
4
4
5
7
8
17
6
18
18
9
21
7
6
6
5
5
4
4
4
3
3
3
3
3
3
3
2
2
Other Non-Cash Items
1
1
2
2
2
2
2
3
3
4
4
7
7
155
157
158
160
12
15
12
(2)
(3)
(7)
(8)
5
4
4
3
2
2
1
1
1
1
1
2
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
1
2
3
4
4
4
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
11
15
0
(1)
0
(10)
(5)
(4)
(7)
3
3
2
(9)
(32)
(33)
(40)
(21)
(2)
(1)
5
(3)
(6)
(4)
2
3
5
4
0
(1)
(0)
3
5
4
(2)
(6)
(8)
Cash from Operating Activities
(8)
N/A
(4)
+55%
(23)
-540%
(28)
-25%
(34)
-20%
(47)
-37%
(46)
+1%
(53)
-14%
(58)
-10%
(58)
0%
(68)
-17%
(65)
+4%
(101)
-55%
(124)
-23%
(126)
-1%
(137)
-9%
(97)
+29%
(78)
+20%
(72)
+8%
(56)
+21%
(53)
+6%
(46)
+13%
(35)
+23%
(29)
+17%
(26)
+12%
(26)
-2%
(24)
+8%
(25)
-5%
(28)
-10%
(26)
+6%
(30)
-15%
(34)
-13%
(37)
-10%
(40)
-7%
(38)
+5%
(33)
+14%
Investing Cash Flow
Capital Expenditures
0
(0)
(0)
(0)
0
0
(0)
(0)
(0)
(1)
(1)
(0)
0
0
1
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
Other Items
(30)
12
(20)
(15)
(68)
(68)
(23)
(34)
20
45
33
41
100
88
92
89
23
3
3
1
17
17
17
16
5
4
4
(57)
(66)
(47)
(51)
23
46
33
41
37
Cash from Investing Activities
(30)
N/A
12
N/A
(20)
N/A
(15)
+25%
(68)
-354%
(68)
+0%
(24)
+65%
(34)
-44%
20
N/A
45
+128%
32
-29%
41
+30%
100
+141%
88
-12%
93
+5%
89
-4%
23
-74%
3
-87%
3
N/A
1
-66%
17
+1 529%
17
-1%
17
-1%
16
-6%
5
-69%
4
-19%
4
+2%
(57)
N/A
(66)
-15%
(47)
+28%
(51)
-8%
23
N/A
46
+99%
33
-30%
41
+26%
37
-9%
Financing Cash Flow
Net Issuance of Common Stock
0
0
50
50
176
176
126
126
1
1
14
5
5
5
45
62
135
135
84
77
5
5
2
2
(0)
(0)
(0)
82
83
83
83
(0)
(0)
(0)
(0)
(0)
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
14
0
0
68
0
0
0
0
(36)
(36)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
(1)
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
0
N/A
0
N/A
50
N/A
49
-2%
175
+253%
175
+0%
125
-29%
126
+1%
1
-100%
1
-6%
28
+5 380%
5
-82%
5
+2%
59
+1 049%
31
-47%
62
+100%
135
+119%
81
-40%
48
-41%
40
-17%
(32)
N/A
(32)
+0%
1
N/A
2
+17%
(0)
N/A
(0)
+60%
(0)
-75%
82
N/A
83
+0%
83
0%
83
+0%
(0)
N/A
(0)
-58%
(0)
-13%
(0)
-3%
(0)
+45%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
(38)
N/A
9
N/A
8
-12%
6
-18%
72
+1 073%
60
-17%
55
-8%
39
-29%
(38)
N/A
(13)
+66%
(8)
+38%
(19)
-134%
4
N/A
23
+467%
(2)
N/A
14
N/A
61
+340%
7
-89%
(21)
N/A
(16)
+26%
(68)
-339%
(61)
+10%
(17)
+72%
(12)
+31%
(21)
-75%
(22)
-6%
(20)
+9%
(0)
+99%
(11)
-3 606%
9
N/A
1
-87%
(11)
N/A
9
N/A
(8)
N/A
2
N/A
4
+79%
Free Cash Flow
Free Cash Flow
(8)
N/A
(4)
+55%
(23)
-539%
(28)
-25%
(34)
-20%
(47)
-37%
(46)
+0%
(53)
-14%
(58)
-10%
(59)
-1%
(69)
-17%
(65)
+5%
(101)
-54%
(123)
-23%
(125)
-1%
(137)
-10%
(97)
+29%
(78)
+20%
(72)
+8%
(56)
+21%
(53)
+6%
(46)
+13%
(35)
+23%
(29)
+17%
(26)
+12%
(26)
-2%
(24)
+8%
(25)
-5%
(28)
-10%
(26)
+6%
(30)
-15%
(34)
-13%
(37)
-10%
(40)
-7%
(38)
+5%
(33)
+14%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett